SCHEMBL25519417

SCHEMBL25519417

Cc1cc(C#N)cc(C)c1-c1ccc(N)nn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NLRP3 Q96P20 3/20 0.39
▸ EGLN2 Q96KS0 4/20 0.38
▸ GRM5 P41594 2/20 0.33
▸ NOS3 P29474 2/20 0.32
▸ NOS1 P29475 2/20 0.32
▸ ABCC3 O15438 1/20 0.32
▸ ESR1 P03372 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ PGR P06401 1/20 0.32
▸ CHRM2 P08172 1/20 0.32
▸ ABCB1 P08183 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ ADRA2A P08913 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CHRM1 P11229 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ DRD1 P21728 1/20 0.32
▸ PTGS1 P23219 1/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ ADORA1 P30542 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22695168 0.75 IL1B (0.47) NLRP3
SCHEMBL2153449 0.71 TTR (0.44) EGLN2KDM4EALDH1A1CYP2A6
SCHEMBL16632485 0.70 ALDH1A1 (0.42) NOS1CYP3A4ALDH1A1
SCHEMBL3366423 0.69 NOS3 (0.43) EGLN2GRM5NOS3NOS1KCNH2
SCHEMBL1182463 0.67 ALDH1A1 (0.50) EGLN2ABCC3ESR1CYP1A2PGR
SCHEMBL22637414 0.67 GRM5 (0.49) GRM5KDM4EALDH1A1
SCHEMBL22545493 0.66 BCAT2 (0.39) NOS3NOS1SLC6A2KDM4EALDH1A1
SCHEMBL22636877 0.66 LRRK2 (0.35) EGLN2CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL22670556 0.66 IL1B (0.60) NLRP3
SCHEMBL17527146 0.65 ALDH1A1 (0.44) EGLN2GRM5NOS3NOS1XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023088987-A1 PYRIDAZINE DERIVATIVES AS INHIBITORS OF NLRP3 F. HOFFMANN-LA ROCHE AG (CH) 2023-05-25 — — WO disclosed
Send feedback